Follow The Filings

TMO position history

The shares of Thermo Fisher Scientific (TMO) that MATRIX ASSET ADVISORS INC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q3: 44,128 shares, $25M, 3.6% of portfolio
  2. 2021 Q4: 21,862 shares, $15M, 1.9% of portfolio, Reduce −50.5%
  3. 2022 Q1: 22,496 shares, $13M, 1.8% of portfolio, Add +2.9%
  4. 2022 Q2: 22,479 shares, $12M, 1.9% of portfolio, Reduce −0.1%
  5. 2022 Q3: 22,350 shares, $11M, 1.9% of portfolio, Reduce −0.6%
  6. 2022 Q4: 22,174 shares, $12M, 1.8% of portfolio, Reduce −0.8%
  7. 2023 Q1: 22,168 shares, $13M, 1.8% of portfolio, Reduce 0.0%
  8. 2023 Q2: 22,195 shares, $12M, 1.6% of portfolio, Add +0.1%
  9. 2023 Q3: 22,234 shares, $11M, 1.6% of portfolio, Add +0.2%
  10. 2023 Q4: 21,967 shares, $12M, 1.5% of portfolio, Reduce −1.2%
  11. 2024 Q1: 21,011 shares, $12M, 1.5% of portfolio, Reduce −4.4%
  12. 2024 Q2: 20,189 shares, $11M, 1.3% of portfolio, Reduce −3.9%
  13. 2024 Q3: 19,753 shares, $12M, 1.4% of portfolio, Reduce −2.2%
  14. 2024 Q4: 19,456 shares, $10M, 1.1% of portfolio, Reduce −1.5%
  15. 2025 Q1: 15,712 shares, $7.8M, 0.86% of portfolio, Reduce −19.2%
  16. 2025 Q2: 42,754 shares, $17M, 1.8% of portfolio, Add +172.1%
  17. 2025 Q3: 21,511 shares, $10M, 0.97% of portfolio, Reduce −49.7%
  18. 2025 Q4: 21,341 shares, $12M, 1.1% of portfolio, Reduce −0.8%
  19. 2026 Q1: 22,547 shares, $11M, 1.0% of portfolio, Add +5.7%
  20. 2026 Q2: 27,668 shares, $14M, 1.1% of portfolio, Add +22.7%
  21. 2026 Q3: 23,947 shares, $16M, 1.3% of portfolio, Reduce −13.4%
Holdings date Value % of holdings Shares Filing date All 13F holders